Sign in
Back
Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality
Journal article   Peer reviewed

Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

Mohamed L. Sorror, Barry E. Storer, Amir T. Fathi, Aaron T. Gerds, Bruno C. Medeiros, Paul Shami, Andrew M. Brunner, Mikkael A. Sekeres, Sudipto Mukherjee, Esteban Peña, …
JAMA oncology, Vol.3(12), pp.1675-1682
2017-09-07
DOI: https://doi.org/10.1001/jamaoncol.2017.2714
PMCID: PMC5824273
PMID: 28880971

Abstract

Online First Original Investigation
This cohort study examines the prognostic association of comorbidities on 1-year mortality after initial therapy of acute myeloid leukemia and a risk-stratifying composite model that incorporates comorbidities, age, and cytogenetic/molecular risks.

Metrics

2 Record Views
99 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.103 Blood Disorders
1.103.155 Acute Myeloid Leukemia
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details